Lyrica CR is a Oral Tablet, Film Coated, Extended Release in the Human Prescription Drug category. It is labeled and distributed by U.s. Pharmaceuticals. The primary component is Pregabalin.
Product ID | 63539-024_9e25a642-501e-4139-bded-aff0ded0ebf9 |
NDC | 63539-024 |
Product Type | Human Prescription Drug |
Proprietary Name | Lyrica CR |
Generic Name | Pregabalin |
Dosage Form | Tablet, Film Coated, Extended Release |
Route of Administration | ORAL |
Marketing Start Date | 2016-01-01 |
Marketing Category | NDA / NDA |
Application Number | NDA209501 |
Labeler Name | U.S. Pharmaceuticals |
Substance Name | PREGABALIN |
Active Ingredient Strength | 165 mg/1 |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2016-01-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA209501 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2016-01-01 |
Ingredient | Strength |
---|---|
PREGABALIN | 165 mg/1 |
SPL SET ID: | 847e8b4e-4c14-4c36-b824-5e1ab6a5db6f |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0071-1026 | Lyrica CR | Lyrica CR |
0071-1027 | Lyrica CR | Lyrica CR |
0071-1029 | Lyrica CR | Lyrica CR |
63539-024 | Lyrica CR | Lyrica CR |
0071-1012 | Lyrica | PREGABALIN |
0071-1013 | Lyrica | PREGABALIN |
0071-1014 | Lyrica | PREGABALIN |
0071-1015 | Lyrica | PREGABALIN |
0071-1016 | Lyrica | PREGABALIN |
0071-1017 | Lyrica | PREGABALIN |
0071-1018 | Lyrica | PREGABALIN |
0071-1019 | Lyrica | PREGABALIN |
0071-1020 | Lyrica | PREGABALIN |